Home > Insider Trading > Filing (0000899243-20-008621)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1631650	Aimmune Therapeutics Inc.	AIMT	Pharmaceutical Preparations (2834)	452748244

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1765473	Andrew Oxtoby	Aimmune Therapeutics, Inc. 8000 Marina Boulevard, Suite 300 Brisbane CA 94005-1884	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.0001 Par Value	Acquisiton	2020-03-13	3,000	$14.76	25,015	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $14.5450 to $14.8500 per share. Information on the exact number of shares purchased at each purchase price can be obtained from the Issuer upon request.
Includes 11,250 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in three successive, equal, annual installments measured from March 1, 2020, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date
Includes 9,000 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from January 19, 2019 subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.